{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:09:05Z","timestamp":1791119345381,"version":"4.1.0"},"reference-count":24,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.3892\/etm.2012.794","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T09:13:06Z","timestamp":1351847586000},"page":"350-354","source":"Crossref","is-referenced-by-count":4,"title":["FSH stimulates expression of the embryonic gene HMGA2 by downregulating let-7 in normal fimbrial epithelial cells of ovarian high-grade serous carcinomas"],"prefix":"10.3892","volume":"5","author":[{"given":"XU-YIN","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JING-XIN","family":"DING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIANG","family":"TAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KE-QIN","family":"HUA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2012,2,11]]},"reference":[{"key":"key20180108122317_b1-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"key20180108122317_b2-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00000478-199611000-00003","article-title":"Micropapillary serous carcinoma of the ovary. A distinctive low\u2013grade carcinoma related to serous borderline tumors","volume":"20","author":"Burks","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"key20180108122317_b3-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"key20180108122317_b4-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"key20180108122317_b5-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nrc2271","article-title":"Roles of HMGA proteins in cancer","volume":"7","author":"Fusco","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"key20180108122317_b6-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ijc.23491","article-title":"HMGA2 gene is a promising target for ovarian cancer silencing therapy","volume":"123","author":"Malek","year":"2008","journal-title":"Int J Cancer"},{"key":"key20180108122317_b7-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4161\/cc.6.21.4845","article-title":"Let-7 Prevents Early Cancer Progression by Suppressing Expression of the Embryonic Gene HMGA2","volume":"6","author":"Park","year":"2007","journal-title":"Cell Cycle"},{"key":"key20180108122317_b8-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1677\/erc.0.0110315","article-title":"FSH and LH serum\/tumor fluid ratios and malignant tumors of the ovary","volume":"11","author":"Rzepka-G\u00f3rska","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"key20180108122317_b9-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-3835(00)00713-8","article-title":"Follicle-stimulating hormone promotes the growth of human epithelial ovarian cancer cells through the protein kinase C-mediated system","volume":"166","author":"Ohtani","year":"2001","journal-title":"Cancer Lett"},{"key":"key20180108122317_b10-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ijc.20478","article-title":"Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells","volume":"112","author":"Ji","year":"2004","journal-title":"Int J Cancer"},{"key":"key20180108122317_b11-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/onc.2009.402","article-title":"Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis","volume":"29","author":"Levanon","year":"2010","journal-title":"Oncogene"},{"key":"key20180108122317_b12-etm-05-01-0350","first-page":"2728","article-title":"Ex Vivo Culture of Primary Human Fallopian Tube Epithelial Cells","author":"Fotheringham","year":"2011","journal-title":"J Vis Exp"},{"key":"key20180108122317_b13-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00001703-200302000-00010","article-title":"Risk factors and risk reduction of breast and ovarian cancer","volume":"15","author":"Brekelmans","year":"2003","journal-title":"Curr Opin Obstet Gynecol"},{"key":"key20180108122317_b14-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/cr.2008.70","article-title":"Activation of the PI3K\/AKT pathway mediates FSH-stimulated VEGF expression in ovarian serous cystadenocarcinoma","volume":"18","author":"Huang","year":"2008","journal-title":"Cell Res"},{"key":"key20180108122317_b15-etm-05-01-0350","first-page":"47","article-title":"Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube","volume":"148","author":"Zheng","year":"1996","journal-title":"Am J Pathol"},{"key":"key20180108122317_b16-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAS.0b013e3181be5d72","article-title":"HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes","volume":"34","author":"Wei","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"key20180108122317_b17-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"key20180108122317_b18-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"key20180108122317_b19-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ng2003","article-title":"Impaired microRNA processing enhances cellular transformation and tumorigenesis","volume":"39","author":"Kumar","year":"2007","journal-title":"Nat Genet"},{"key":"key20180108122317_b20-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"11400","DOI":"10.1073\/pnas.0704372104","article-title":"Let-7 expression defines two differentiation stages of cancer","volume":"104","author":"Shell","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108122317_b21-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1126\/science.1137999","article-title":"Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation","volume":"315","author":"Mayr","year":"2007","journal-title":"Science"},{"key":"key20180108122317_b22-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1101\/gad.1540407","article-title":"The tumor suppressor microRNA let-7 represses the HMGA2 oncogene","volume":"21","author":"Lee","year":"2007","journal-title":"Genes Dev"},{"key":"key20180108122317_b23-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-4598-6-5","article-title":"High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma","volume":"6","author":"Hebert","year":"2007","journal-title":"Mol Cancer"},{"key":"key20180108122317_b24-etm-05-01-0350","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/modpathol.2010.49","article-title":"HMGA2: A biomarker significantly overexpressed in high-grade ovarian serous carcinoma","volume":"23","author":"Mahajan","year":"2010","journal-title":"Modern Pathology"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2012.794\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T16:38:25Z","timestamp":1515429505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2012.794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,11]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,2,11]]},"published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.3892\/etm.2012.794"],"URL":"https:\/\/doi.org\/10.3892\/etm.2012.794","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,11]]}}}